FDA Rejects Antidepressant as COVID Treatment

Request for approval submitted by University of Minnesota professor. The Food and Drug Administration (FDA) published a document last week that declined the emergency use authorization of the…

Read More

President Invokes Defense Act for Baby Formula

Administration authorizes flights from overseas with imports.  The president’s administration has invoked the Defense Production Act to increase the production of baby formula. The White House reported the…

Read More

House Plans May 25 Hearing on Formula Shortage

 Congress seeks to better understand causes to find solutions. The House Energy and Commerce Committee announced that they have scheduled a hearing for May 25th to gather information…

Read More

Baby Formula Shortage Concerns Parents and Pediatricians

FDA shutdown of Michigan manufacturer contributing to lowered supply. Supply chain and delivery issues are a part of a nationwide shortage of infant and baby formula, causing parents…

Read More

House Holds Prescription Opioid Hearing

CEO of prescription drug consulting company testifies. The House Oversight and Reform Committee conducted a hearing on Wednesday, where they questioned the CEO of the prescription drug consulting…

Read More

FDA Extends Antibody Review by Three Months

Monoclonal antibodies have yet to receive full FDA approval. Regeneron Pharmaceuticals Inc. announced last week that the U.S. Food and Drug Administration (FDA) has extended its review of…

Read More

FDA Law Closes E-Cigarette Loopholes

Addresses synthetic nicotine as well as natural nicotine. A law that took effect last week will allow the Food and Drug Administration (FDA) to regulate both artificial nicotine…

Read More

House Legislators Seek Release of FDA Vaccine Data

Safety and efficacy information being sought.  The Food and Drug Administration has received requests from representatives in the House to release its current and future safety and efficacy…

Read More

FDA Says Current Vaccines Don’t Suit New COVID Strain

Raises question of what to do with additional variants. This week, a panel of outside experts gathered at the Food and Drug Administration (FDA) headquarters to discuss how…

Read More

FDA Approves Childhood Epilepsy Drugs

Seizure medications authorized for patients 2 years and older. On Monday, the Food and Drug Administration approved a treatment for seizures in patients two years old and above.…

Read More

Back to top
FE3